The Valley Desk

Clinical trial reportCancerPublished

Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma: A US subgroup analysis from MagnetisMM-3

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Cancer
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Antineoplastic Agents; Antibodies, Bispecific; Adult; Aged; Aged, 80 and over; Middle Aged; United States; Female; Male
PubMed ID
42159085
Added to directory
Source checked

Report a correction or request removal